MIR5092

Across TCGA pan-cancer cohorts, MIR5092 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR5092 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MIR5092 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR5092 expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

READ, KIRC, and LUSC are the cancer types where MIR5092 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	II,III,IV	0.187	0.733	<.001	81	view →
KIRC	OS	Tertile	All	0.796	0.890	.008	48	view →
LUSC	OS	Tertile	III,IV	0.171	0.795	<.001	24	view →
DLBC	DFS	Tertile	All	0.512	0.940	.007	18	view →
THYM	OS	Tertile	All	0.889	0.975	.015	12	view →
OV	OS	Tertile	II,III,IV	0.747	0.682	.046	12	view →
BLCA	DFS	Tertile	IV	0.160	0.482	.017	9	view →
LIHC	OS	Tertile	III,IV	0.118	0.543	.020	9	view →
SKCM	DFS	Tertile	All	0.922	0.727	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR5092–READ (DFS)

Open the READ breakdown →